Zobrazeno 1 - 10 of 46 pro vyhledávání: '"Kazuo Tsubaki"'
1
Akademický článek
Incidence of acute kidney disease after receiving hematopoietic stem cell transplantation: a single-center retrospective study
Autor: Akira Mima, Kousuke Tansho, Dai Nagahara, Kazuo Tsubaki
Publikováno v: PeerJ, Vol 7, p e6467 (2019)
Background Previous reports have shown that acute kidney injury (AKI) is common after hematopoietic stem cell transplantation (HSCT), which is a crucial treatment for patients with hematological disorders. AKI could increase mortality and induce adve
Externí odkaz: https://doaj.org/article/1f93cb3e084b478ab873e6696c357719
Zobrazit plný text záznamu
3
Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial
Autor: Shuhei Kawata, Fumiaki Urase, Hitoshi Hanamoto, Mitsuhiro Matsuda, Hirohiko Shibayama, Jun Ishikawa, Itaru Matsumura, Kazuo Tsubaki, Yasuyoshi Morita, Terufumi Yamaguchi, Yasuhiro Maeda
Publikováno v: Cancer Science
Although azacitidine is the first-line drug for higher-risk myelodysplastic syndrome (MDS) patients, its efficacy for lower-risk MDS remains unestablished. Therefore, we conducted a prospective study to examine the efficacy and safety of a 5-day regi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e64a84dda0bacfdd1f24864398d08cc9
https://doi.org/10.1111/cas.13739
Zobrazit plný text záznamu
7
Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation
Autor: Yasuhisa Sando, Noboru Asada, Keiko Fujii, Yusuke Meguri, Nobuharu Fujii, Kazuo Tsubaki, Kyosuke Saeki, Naomi Asano, Keisuke Seike, Makoto Nakamura, Daisuke Ennishi, Ken-ichi Matsuoka, Yoshinobu Maeda, Hisakazu Nishimori, Fumio Otsuka, Shigenori Ohkuma, Yasushi Hirata, Kazunori Naito
Publikováno v: TransfusionREFERENCES. 60(3)
BACKGROUND Cross-matched platelet (cross-matched PLT) transfusion is effective for immune-mediated platelet transfusion refractoriness (PTR), but is more costly and time-consuming for physical cross-match than using standard PLT units. Recent studies
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103dd1717b61d989279e7f3bb92252d6
https://pubmed.ncbi.nlm.nih.gov/33217024
Zobrazit plný text záznamu
8
Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms
Autor: Yasuhiro Taniguchi, Takahiro Kumode, Kazuto Nishio, Yasuyoshi Morita, Hitoshi Hanamoto, Shinya Rai, Kazuko Sakai, Hirokazu Tanaka, Kentarou Serizawa, Kazuo Tsubaki, Espinoza J. Luis, Itaru Matsumura, Keigo Sano
Publikováno v: International journal of hematology. 106(5)
Myeloproliferative neoplasms (MPNs), including polycythemia vera and essential thrombocythemia, are frequently associated with thrombotic complications. Prevention of thrombotic events is thus a primary aim of the current treatment for these disorder
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9835f0768549433d4f10c197ee64b158
https://pubmed.ncbi.nlm.nih.gov/28780601
Zobrazit plný text záznamu
9
Once-weekly Bortezomib in Combination with Reduced-dose Dexamethasone and Continuous Low-dose Oral Cyclophosphamide for Elderly Patients with Multiple Myeloma
Autor: Keiko Yamazaki, Hideo Yagi, Hitoshi Hanamoto, Syuji Minamoto, Kazuo Tsubaki, Aki Fujii, Mariko Fujita
Publikováno v: Journal of Hematology & Thromboembolic Diseases.
CyBorD is one of the most effective triplet regimens for both transplant-eligible and ineligible patients with multiple myeloma. In comparison, once-weekly bortezomib induction therapy with a reduced dosage of dexamethasone (modified-CyBorD) showed l
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c2c16685beb1b2bfc11dcb05fa5bb2ed
https://doi.org/10.4172/2329-8790.1000261
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje